Literature DB >> 28674262

Time-Dependent Alterations of Vancomycin-Induced Nephrotoxicity in Mice.

Masaki Takigawa1,2, Hirofumi Masutomi1, Yuki Kishimoto1, Yoshitomo Shimazaki1,2, Yoshitomo Hamano3, Yoshitaka Kondo1, Tomio Arai4, Jaewon Lee5, Toshihiro Ishii6, Yoshiko Mori2, Akihito Ishigami1.   

Abstract

Vancomycin hydrochloride (VCM) is a glycopeptide antibiotic that is commonly used against methicillin-resistant, Gram-positive cocci despite the nephrotoxic side effects. VCM-induced nephrotoxicity has been reported in 5-28% of recipient patients. Therefore, renal failure induced by VCM has become an important clinical problem. However, the exceedingly complex mechanism of VCM-induced nephrotoxicity is not fully understood. Therefore, this study was designed to clarify time-dependent alterations of VCM-induced nephrotoxicity in mice as a step toward decreasing the risks of kidney injury associated with VCM therapy. VCM was injected intraperitoneally into mice at a dose of 400 mg/kg body weight at 24-h intervals for 3, 5, 7, and 14 d. At 24 h after the last injection, we examined histopathological alterations of the kidney as well as blood biochemistry. VCM administration resulted in a decrease of body weight and increase of kidney weight. Histological examination revealed renal damage such as dilated proximal tubules with occasional casts and interstitial fibrosis in VCM-treated mice. Furthermore, immunohistochemical staining with anti-CD10 and anti-single-stranded DNA antibodies highlighted damaged renal proximal tubules with marked dilatation as well as numerous apoptotic cells as early as day 4 of VCM-treatment. The severity of symptoms progressed until day 15. These results suggest that VCM-induced renal damage and incipient renal failure begin soon after the start of treatment and progressively worsen. This is the first report describing the time-dependence of VCM-induced nephrotoxicity in mice and depicting a model that clarifies the mechanisms of this tissue damage.

Entities:  

Keywords:  CD10; apoptosis; kidney; nephrotoxicity; vancomycin

Mesh:

Substances:

Year:  2017        PMID: 28674262     DOI: 10.1248/bpb.b16-00932

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model.

Authors:  Miao He; Ernane Souza; Aleksas Matvekas; Ryan L Crass; Manjunath P Pai
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

2.  Transdermal Delivery of High Molecular Weight Antibiotics to Deep Tissue Infections via Droplette Micromist Technology Device (DMTD).

Authors:  Lakshmi Pulakat; Howard H Chen; Madhavi P Gavini; Lauren A Ling; Yinian Tang; Alexander Mehm; Gregory L Martin; Corinna N Beale; Brian P Mooney; Hongmin Sun
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

3.  Age-dependent changes in vancomycin-induced nephrotoxicity in mice.

Authors:  Masaki Takigawa; Hirofumi Masutomi; Yoshitomo Shimazaki; Tomio Arai; Jaewon Lee; Toshihiro Ishii; Yoshiko Mori; Akihito Ishigami
Journal:  J Toxicol Pathol       Date:  2018-12-10       Impact factor: 1.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.